Michael Weigel
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
-
- Reproductive Health and Technologies 4
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Louis Bujan (1 shared paper)Yvon Englert (1 shared paper)Juliette Guibert (1 shared paper)Lital Hannah Hollander (1 shared paper)Jeanine Ohl (1 shared paper)Mathieu Coudert (1 shared paper)Carole Gilling‐Smith (1 shared paper)Augusto Enrico Semprini (1 shared paper)
- Journals
- Annals of Oncology (3 papers)International Journal of Gynecological Cancer (2 papers)Breast Cancer Research (2 papers)Journal of Histochemistry & Cytochemistry (2 papers)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Michael Weigel
41 papers receiving 1.2k citations
Michael Weigel's Hit Papers
Peers
Comparison fields: 5 of 86
- Reproductive Medicine 213
- Cancer Research 253
- Oncology 356
- Obstetrics and Gynecology 64
- Infectious Diseases 145
Countries citing papers authored by Michael Weigel
This map shows the geographic impact of Michael Weigel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Weigel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Weigel more than expected).
Fields of papers citing papers by Michael Weigel
This network shows the impact of papers produced by Michael Weigel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Weigel. The network helps show where Michael Weigel may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Weigel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 321 |
| 2 | 2007 | 155 | |
| 3 | 2020 | 127 | |
| 4 | 2014 | 110 | |
| 5 | 1999 | 108 | |
| 6 | 2020 | 67 | |
| 7 | 2008 | 49 | |
| 8 | 2011 | 49 | |
| 9 | 2017 | 44 | |
| 10 | 2021 | 29 | |
| 11 | 2004 | 27 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 15 | |
| 14 | 1989 | 15 | |
| 15 | 2018 | 13 | |
| 16 | 1998 | 13 | |
| 17 | 2019 | 13 | |
| 18 | 2001 | 9 | |
| 19 | 1994 | 7 | |
| 20 | 2005 | 7 |
About Michael Weigel
Michael Weigel is a scholar working on Reproductive Medicine, Cancer Research, Obstetrics and Gynecology, Infectious Diseases and Endocrinology, Diabetes and Metabolism, having authored 46 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), HIV/AIDS Research and Interventions (7 papers), Reproductive Health and Technologies (4 papers), Hormonal Regulation and Hypertension (3 papers), Breast Lesions and Carcinomas (3 papers), Estrogen and related hormone effects (3 papers), HER2/EGFR in Cancer Research (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). The work is most often cited by research in Reproductive Medicine (213 citations), Cancer Research (253 citations), Oncology (356 citations), Obstetrics and Gynecology (64 citations) and Infectious Diseases (145 citations). Michael Weigel has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Louis Bujan, Yvon Englert, Juliette Guibert, Lital Hannah Hollander, Jeanine Ohl, Mathieu Coudert, Carole Gilling‐Smith, Augusto Enrico Semprini, Pietro Luigi Vernazza and Elisabeth Falkenstein. Their work appears in journals such as Annals of Oncology, International Journal of Gynecological Cancer, Breast Cancer Research, Journal of Histochemistry & Cytochemistry and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.